Immune Pharmaceuticals Inc (fka IMNPQ)

[Letterpenny]

On a positive note, it looks like Naya will be carrying forward with phase 1 clinical studies for the NK cell product. I believe they’ve said 12 -24 months to get to the targeted goal. So hopefully 2025 / 2026 will give us a good data drop with possibly some liquidity to follow. Stay tuned man. Finally we got some dates to link milestones down the road. Hopefully in the new year they’ll drop some more dates when they do the other mergers. Hopefully they get this first scam done by April. Then start up Satellos and finish that up by June / July. That one should be relatively simple. A simple deal there. ESHA will most likely bring the most data for us Longs. Then in the fall and winter it will just be another pony show until 2025. Good times people. Good times. Hula Hula Cuckoo Penny